The research, conducted within the Dutch INSIGHT study and embedded in the national BETER survivorship-care infrastructure, examined how much adult Hodgkin lymphoma survivors know about their own long-term health risks and which factors predict better or worse knowledge. Led by Sophia K. Smith of Duke University together with Annelies Nijdam, Flora E. van Leeuwen, Michael Schaapveld, and a broad network of Dutch hematology and radiation oncology specialists, the study surveyed 370 survivors with a median age of 55.2 years at the time of the survey, 53 percent of whom were women. Participants completed a multi-domain questionnaire probing their awareness of five categories of late effects: endocrine complications such as thyroid dysfunction and infertility, cardiovascular disease, subsequent cancers, infection risk, and treatment-related symptoms.

To quantify knowledge in a way that allowed comparison across respondents, the team constructed a 12-item sex-comparable knowledge index. Items were scored using partial-credit rules, meaning respondents could receive recognition for partially correct answers rather than facing an all-or-nothing scoring scheme. Because some participants left questions unanswered, the researchers used multiple imputation—a statistical technique that fills in missing values by drawing plausible values repeatedly from predictive distributions, thereby preserving uncertainty rather than pretending missing answers were known. This approach, grounded in the work of Rubin and refined through fully conditional specification methods, is considered methodologically preferable to simply deleting incomplete cases, which can bias results when data are not missing at random.

The headline finding is sobering. Overall survivorship knowledge was low, with a median score of just 38.9 percent correct responses across the index. In other words, the typical survivor in the study answered fewer than four of the knowledge items correctly, even though all participants were part of a national program specifically designed to deliver risk-based long-term follow-up. The researchers emphasize that knowledge was also highly heterogeneous: some survivors demonstrated solid understanding of their risk profile, while others knew very little about the threats most relevant to their treatment history.

Perhaps the most consequential finding is what predicted knowledge. When the team applied multiple linear regression models—estimated with heteroskedasticity-consistent standard errors to guard against unequal variability in residuals—the strongest independent associations were not clinical but demographic. Female sex and younger age showed the largest relationships with higher knowledge scores, even after accounting for treatment exposures and survivorship-care utilization. This means that men and older survivors, two groups with substantial late-effect burdens, systematically knew less about the risks they face. The implication is uncomfortable: the patients who may need to be most vigilant about screening and prevention may be the least equipped to engage with that vigilance.

Treatment-related factors did matter, however. Survivors who had received chemotherapy, those exposed to splenic radiotherapy or who had undergone splenectomy, and those who had attended a greater number of survivorship-care visits all demonstrated higher knowledge scores. The first two associations make intuitive sense from an information-exposure standpoint: patients who received visibly consequential treatments, or who lost their spleen—a well-known cause of lifelong susceptibility to encapsulated bacterial infections—were more likely to have been counseled about specific risks such as the need for vaccinations against pneumococcus, meningococcus, and Haemophilus influenzae. The association between visit frequency and knowledge suggests that repeated contact with survivorship services does translate into better-informed patients, even if the overall level of knowledge remains discouragingly modest.

One of the most technically interesting aspects of the study concerns how knowledge was measured. The researchers distinguished between categorical knowledge items, which ask survivors to identify whether a given late effect is a recognized risk, and numeric risk-estimation items, which require respondents to estimate magnitudes—for example, roughly quantifying their elevated risk of a second cancer. Numeric items showed consistently lower correct response rates than categorical items. This pattern aligns with cognitive science literature on risk approximation, which shows that even numerate adults struggle to reason with probabilistic quantities under objective risk. Survivors may know that cardiovascular disease is “a risk” without grasping how large that risk is, when it peaks, or how it compares to the general population—and it is precisely this quantitative understanding that drives informed screening decisions.

The stakes of this knowledge gap are far from abstract. Long-term follow-up studies of Hodgkin lymphoma patients, including the Dutch group’s own work on cause-specific mortality and the landmark analysis of second cancer risk up to 40 years after treatment published in the New England Journal of Medicine, have documented elevated and persistent excess risks of cardiovascular disease and secondary malignancies decades after curative therapy. Effective risk-based care depends on survivors recognizing symptoms that warrant attention, adhering to surveillance protocols such as echocardiography or mammography, adopting preventive behaviors, and seeking timely care. A survivor who does not know that chest irradiation raises lifetime cardiac risk is unlikely to prioritize cardiovascular screening; one who does not understand post-splenectomy infection risk may skip recommended vaccinations. Knowledge, in this sense, is the cognitive foundation on which the entire architecture of risk-based survivorship care rests.

The study’s authors argue that their findings call for a shift in how survivorship education is designed and delivered. Because knowledge varied primarily by demographic characteristics rather than by clinical risk alone, uniform educational materials appear insufficient. Instead, the researchers propose targeted, demographically tailored educational strategies—approaches that specifically reach male survivors and older survivors, the two groups with the lowest knowledge in this cohort. The finding that numerical risk comprehension is especially poor suggests that communication should move beyond bare percentages toward formats known to improve risk understanding, such as natural frequencies, icon arrays, and visual risk portrayal. Encouragingly, prior work within this same research lineage, including a pilot randomized controlled trial of an online intervention designed to increase late-effects knowledge and screening awareness among Hodgkin lymphoma survivors, suggests that digital educational tools can move the needle on knowledge outcomes.

The study also carries implications for health equity within survivorship care. Risk-based survivorship programs—increasingly codified in guidelines from bodies such as the National Comprehensive Cancer Network—allocate surveillance intensity according to each patient’s treatment exposures. But such a system only works if patients understand and engage with their prescribed follow-up. If knowledge is systematically lower among men and older adults, these groups may derive less benefit from otherwise well-designed programs, compounding existing disparities. The authors note that as cancer survivor populations grow rapidly worldwide, ensuring equitable engagement in long-term follow-up becomes a public health priority, not merely a patient-communication nicety.

The INSIGHT study itself represents an unusually rigorous framework for asking these questions. As a multicenter retrospective cohort study with a quasi-experimental design, it draws on patients recruited across a national network of Dutch hematology and radiation oncology departments, from the Netherlands Cancer Institute and Amsterdam UMC to Erasmus MC, Leiden University Medical Center, University Medical Center Utrecht, University Medical Center Groningen, and multiple regional hospitals. The study was supported by the Netherlands Organization for Health Research and Development (ZonMw), the Dutch Cancer Society, the Dutch Ministry of Health, Welfare, and Sport, and the Duke University School of Nursing. Data availability is restricted by privacy regulations, but datasets can be obtained from the corresponding author with appropriate approvals.

For survivors, the message of this research is simultaneously cautionary and empowering. Being cured of Hodgkin lymphoma does not mean the medical story ends at remission; it means entering a decades-long phase in which informed self-advocacy matters enormously. For clinicians, the study is a reminder that delivering risk information is not the same as transmitting it, and that comprehension must be verified, not assumed—particularly for male and older patients. For health systems, it suggests that survivorship programs should embed structured knowledge assessment and tailored education into routine care, treating patient understanding as an outcome to be measured and improved, just like blood pressure or screening adherence. As the population of Hodgkin lymphoma survivors continues to expand, closing this knowledge gap may prove as important to long-term survival as any advance in front-line therapy.

Childhood cancer survivors constitute a uniquely vulnerable population; their battle with oncological disease often culminates in life-saving interventions, which paradoxically impose heightened risks for chronic health problems, notably cardiovascular disease. Historically, these secondary health effects were largely perceived as inevitable consequences of intensive treatment regimens. However, emerging epidemiological evidence challenges this deterministic outlook by highlighting modifiable lifestyle risk factors as major contributors to post-cancer morbidity. This paradigm shift underscores an urgent need to integrate lifestyle interventions within survivorship care protocols to improve long-term outcomes.

One of the hallmark studies, published in the prestigious journal Nature Communications, meticulously tracked over 18,000 childhood cancer survivors for a longitudinal period extending up to three decades. Utilizing advanced observational methodologies, the investigators established strong correlations between adverse lifestyle behaviors—such as physical inactivity, obesity, tobacco use, and excessive alcohol consumption—and the prevalence of chronic health conditions in this cohort. Remarkably, their analytical models demonstrated that these lifestyle factors collectively contribute a disease burden comparable to that associated with prior cancer treatments, upending previous dogma that placed therapeutic exposures as the predominant risks.

The implications of these findings are profound. Arguably, the most encouraging aspect is the modifiability of lifestyle factors compared to the irreversibility of prior cancer therapy exposures. Aron Onerup, a pediatrician and prominent researcher involved in both studies, emphasizes that this newfound understanding empowers survivors and healthcare providers with actionable strategies. “Whereas treatments administered in the past are permanent, lifestyle behaviors can be altered at any stage of life,” he explains, highlighting the immense potential to improve survivorship quality through targeted health promotion.

In a complementary investigation published in JACC: CardioOncology, the research team focused on a specific subset of survivors—those treated for Hodgkin’s lymphoma during childhood or adolescence. This malignancy, originating in the lymph nodes, requires intensive therapies known for long-term toxicity. The study encompassed data from over 2,300 individuals, revealing that inadequate physical activity results in a 1.4-fold increase in cardiovascular disease incidence compared to the general population’s overall burden. Strikingly, this risk amplification dwarfs the impact of insufficient exercise observed in broader demographics, despite minimal differences in lifestyle habits, underscoring heightened vulnerability among Hodgkin’s lymphoma survivors.

These groundbreaking insights reinforce the critical role of structured physical activity as a protective agent, capable of attenuating the deleterious sequelae of cancer therapies. The biological mechanisms underlying this phenomenon likely involve multifaceted improvements in endothelial function, systemic inflammation reduction, and cardiorespiratory fitness enhancement. Moreover, engaging survivors in regular exercise may positively influence psychosocial health and adherence to other beneficial lifestyle behaviors, creating a compound effect that further diminishes chronic disease risks.

The broader scientific consensus emerging from these studies calls for a paradigm shift in survivorship care models—one that systematically incorporates lifestyle assessment and intervention as foundational elements of long-term follow-up. Traditionally, post-cancer surveillance prioritized medical complications directly attributable to treatment-related toxicity, sometimes overlooking the modifiable external risk factors. There is now compelling evidence to advocate for multidisciplinary approaches encompassing nutrition counseling, physical rehabilitation, smoking cessation programs, and alcohol moderation support tailored to survivor needs throughout childhood, adolescence, and adulthood.

Aron Onerup and colleagues are pioneering efforts to translate these findings into pragmatic clinical practices by developing and rigorously testing intervention strategies aimed at fostering sustainable healthy lifestyle adoption. Their approach recognizes the unique challenges faced by survivors, including psychosocial stressors, treatment-induced fatigue, and potential socioeconomic barriers. Early pilot programs incorporating behavior change theories, motivational interviewing, and digital health technologies show promise in enhancing engagement and efficacy, representing the frontier of personalized survivorship care.

Integration of lifestyle modification initiatives within national healthcare frameworks is already underway in some regions, reflecting a growing acknowledgment of their necessity. For instance, Sweden’s national healthcare program for childhood cancer follow-up now emphasizes comprehensive profiling of lifestyle habits to identify at-risk individuals and tailor appropriate supports. This systematic inclusion can facilitate earlier detection of detrimental behaviors and timely implementation of preventative measures, thereby potentially reducing the incidence of late complications and improving overall survival quality.

Beyond individual benefits, this research harbors broader public health implications. With global improvements in childhood cancer survival rates, the population of survivors is expanding markedly, translating into an increasing societal burden of chronic health complications that strain healthcare systems. By reducing modifiable lifestyle risks, there is an opportunity to alleviate this burden, decrease healthcare costs, and enhance life expectancy and productivity among survivors, aligning with health equity and sustainable care goals.

It must be noted, however, that lifestyle interventions complement rather than replace medical management. Holistic survivorship care mandates continued vigilance against cancer recurrence and vigilant monitoring of organ function perturbed by past treatments. This dual-axis approach ensures comprehensive risk reduction while maintaining therapeutic safety. Additionally, further research is required to refine risk stratification models integrating genetic predispositions, treatment exposures, and lifestyle parameters to optimize personalized care plans.

In conclusion, these seminal studies illuminate the transformative potential of a healthy lifestyle in reshaping the long-term health trajectory of childhood cancer survivors. By embracing physical activity, maintaining healthy weight, avoiding tobacco, and moderating alcohol intake, survivors can proactively counterbalance the somatic toll of prior cancer treatments, thereby enhancing their quality of life and longevity. The compelling evidence finally empowers clinicians and survivors alike to champion lifestyle as a vital component of survivorship, marking a new era in pediatric oncology care that transcends cure to encompass thriving beyond cancer.

Subject of Research: People

Article Title: Potential for risk reduction of chronic health conditions through lifestyle in childhood cancer survivors

Web References: http://dx.doi.org/10.1038/s41467-026-73517-y

Image Credits: Photo: Anna Onerup

Keywords: childhood cancer survivors, cardiovascular disease, lifestyle factors, physical activity, obesity, smoking, alcohol intake, long-term follow-up, risk reduction, pediatric oncology, survivorship care, Hodgkin’s lymphoma